Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke … (NCT06098508) | Clinical Trial Compass
CompletedNot Applicable
Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients
United States3 participantsStarted 2024-07-23
Plain-language summary
This study assesses the feasibility and safety of performing osteopathic manual treatment (OMT) for hemiplegic shoulder pain in stroke patients. This study's participants will be adults with a first-time stroke diagnosis in the past 5 years and shoulder pain on the same side affected by stroke. Eligible participants will be placed on study for approximately 6 weeks and given either OMT or a sham treatment each week.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients must be at least 18 years or older to participate in the study
* Presence of shoulder pain on the side of the body affected by stroke
* Patients must have a diagnosis of a first-time stroke within the past 5 years
* Stroke type must be subcortical, brainstem, and/or right-MCA stroke. Participants with multiple stroke types within the first-time diagnosis may be included
Exclusion Criteria:
* Presence of an active systemic or localized infection requiring antibiotic therapy
* Presence of fracture in the area being treated
* Presence of open wound in the area being treated
* Presence of rheumatoid arthritis
* Presence of known active malignancy
* Presence of shoulder pain on the affected side within 3 months prior to stroke
* Patients with left-MCA stroke diagnosis who demonstrate the presence of aphasia based on the Mississippi Aphasia Screening Test (MAST)
* Patients who demonstrate hemispatial visual neglect based on screening motor-free visual perception test (MFVPT)
* Patients already receiving any type of manual therapy by a certified therapist through their standard-of-care treatment
* Patients who do not wish to participate
* Patients who are not fit as judged by the study team
* Patients who lack the capacity to consent for enrollment in the study based on the University of California San Diego Brief Assessment of Capacity to Consent
What they're measuring
1
Feasibility Assessment
Timeframe: From enrollment to the end of treatment at 6 weeks